About Sunmax Laboratories Private Limited
Data last updated:
Sunmax Laboratories Private Limited is a private limited company based in Rajahmundry, , India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 August 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24239AP2006PTC050802. Its GSTIN is 37AAKCS6134J1ZZ (Andhra Pradesh).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Muralidhara Rao Guttula (Managing Director) and Koteswari Guthula.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Rajahmundry, Andhra Pradesh.
As per the financials filed for FY 2023, the company reported a revenue of ₹55.21 Lakh, a decline of 47% compared to the previous year. For the same year it recorded a net profit of ₹84,870 (net margin 1.5%) and EBITDA of ₹2.45 Lakh (EBITDA margin 4.4%). Revenue has declined at a compounded annual rate (CAGR) of 21% over three years and 9% over five years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sunmaxlabs.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address68 – 20 – 02/A Upstair, Revenue Colony, Rajahmundry, Andhra Pradesh, India – 533106
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Sunmax Laboratories Private Limited
The main business activity of Sunmax Laboratories is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Sunmax Laboratories Private Limited FY 2023 filings available
Sunmax Laboratories Private Limited reported revenue of ₹55.21 Lakh (down 47% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Sunmax Laboratories Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 9% over five years, including a 47% fall in the latest year. EBITDA rose 128% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Sunmax Laboratories Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.45 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹84,870 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Sunmax Laboratories Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Sunmax Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Sunmax Laboratories Private Limited
Sunmax Laboratories Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| M R Pharmaceutical Technologies Private Limited | ₹55.81 Lakh (FY 2024) | •••• | •••• | 85.0% | •••• | New Delhi, Delhi, India |
| Woodrock Healthcare Private Limited | ₹55.71 Lakh (FY 2025) | •••• | •••• | -6.0% | •••• | Vadodara, Gujarat, India |
| Wellcare Agrovet Private Limited | ₹55.62 Lakh (FY 2024) | •••• | •••• | -33.0% | •••• | Lucknow, Uttar Pradesh, India |
| Rhythmed Pharma Private Limited | ₹55.58 Lakh (FY 2025) | •••• | •••• | 240.0% | •••• | Nashik, Maharashtra, India |
| Kelvin Healthcare Private Limited | ₹55.46 Lakh (FY 2024) | •••• | •••• | -20.0% | •••• | Bilaspur, Chhattisgarh, India |
| Sunmax Laboratories Private Limited this company | ₹55.21 Lakh (FY 2023) | •••• | •••• | -47.0% | •••• | Rajahmundry, Andhra Pradesh, India |
| Karofer Healthcare Private Limited | ₹55.14 Lakh (FY 2025) | •••• | •••• | 658.0% | •••• | Ahmedabad, Gujarat, India |
| Cadorel Organics Private Limited | ₹54.95 Lakh (FY 2023) | •••• | •••• | -33.0% | •••• | Ahmedabad, Gujarat, India |
| Heptagon Life Sciences Private Limited | ₹54.86 Lakh (FY 2025) | •••• | •••• | 1.0% | •••• | Chennai, Tamil Nadu, India |
| Aurus Healthcare (OPC) Private Limited | ₹54.85 Lakh (FY 2025) | •••• | •••• | 16.0% | •••• | Jhansi, Uttar Pradesh, India |
| Medchem International Limited | ₹54.84 Lakh (FY 2024) | •••• | •••• | -64.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Sunmax Laboratories by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Sunmax Laboratories Private Limited
Auditor information for Sunmax Laboratories Private Limited provides details about the firm responsible for auditing the company's financial statements and ensuring compliance with regulatory requirements.
Board of Directors of Sunmax Laboratories Private Limited
Sunmax Laboratories has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Koteswari Guthula | Director | 03 Aug 2006 | 20 Years 2 Months | Current |
| Muralidhara Rao Guttula | Managing Director | 03 Aug 2006 | 20 Years 2 Months | Current |
Ownership and Shareholding of Sunmax Laboratories Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Sunmax Laboratories Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Aug 2007 | State Bank of India | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Sunmax Laboratories Private Limited
Employment history and EPFO contributions of people linked to Sunmax Laboratories.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Sunmax Laboratories Private Limited
Sunmax Laboratories Private Limited has 2 board changes on record since 2006: 2 appointments. The latest: Koteswari Guthula was appointed as Director on 03 Aug 2006.
Credit Ratings, Litigation & Regulatory Alerts for Sunmax Laboratories Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Sunmax Laboratories Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sunmax Laboratories Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Sunmax Laboratories Private Limited
Sunmax Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAKCS6134J1ZZ | Andhra Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sunmax Laboratories Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sunmax Laboratories Private Limited
Sunmax Laboratories is an active private limited company based in Rajahmundry, , India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 August 2006 (20+ years old) and is registered under CIN U24239AP2006PTC050802.
Sunmax Laboratories reported revenue of ₹55.21 Lakh for FY 2023 (down 47% YoY).
Sunmax Laboratories has 2 current directors:
- Muralidhara Rao Guttula - Managing Director
- Koteswari Guthula - Director
Sunmax Laboratories reported a net profit of ₹84,870 (net margin 1.5%) and EBITDA of ₹2.45 Lakh (EBITDA margin 4.4%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Sunmax Laboratories is -21% over three years and -9% over five years. In the latest year (FY 2023) revenue fell 47%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Sunmax Laboratories is 37AAKCS6134J1ZZ, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Sunmax Laboratories is U24239AP2006PTC050802. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sunmax Laboratories was incorporated on 03 August 2006, making it 20+ years old. It is registered with the Registrar of Companies, Vijayawada.
The peers of Sunmax Laboratories by revenue are M R Pharmaceutical Technologies Private Limited, Woodrock Healthcare Private Limited, Wellcare Agrovet Private Limited, Rhythmed Pharma Private Limited, Kelvin Healthcare Private Limited and 5 more, all in the Pharma industry (Formulations).
Koteswari Guthula was appointed as Director on 03 Aug 2006. Muralidhara Rao Guttula was appointed as Managing Director on 03 Aug 2006.
Sunmax Laboratories can be reached through the website sunmaxlabs.com. Its registered office is in Rajahmundry, , India.